InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Burgess Daniel d, Director. Insider active across 2 companies, notably Nabriva Therapeutics plc. In total, 4 reports have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €3k. Activity tracked since 28 July 2021. The latest transaction was disclosed on 7 January 2026 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Daniel D. Burgess is a Board Member at Nabriva Therapeutics plc. He contributes to the governance of the company by participating in strategic decision-making and ensuring operational compliance. His role is important for the success and growth of the company.